MYGN: Myriad Genetics, Inc. Stock

by  •  • Comments Off on MYGN: Myriad Genetics, Inc. Stock

SIC 2835 – In Vitro and In Vivo Diagnostic Substances

Valuation
Market Cap ($M) 1,682.90
Enterprise Value ($M) 1,589.30
Book Value ($M) 783.20
Book Value / Share 8.66
Price / Book 2.15
NCAV ($M) -49.70
NCAV / Share -0.55
Price / NCAV -33.86

Profitability (mra)
Return on Invested Capital (ROIC) -0.28
Return on Assets (ROA) -0.23
Return on Equity (ROE) -0.32

Liquidity (mrq)
Quick Ratio 1.87
Current Ratio 2.01

Balance Sheet (mrq) ($M)
Current Assets 313.60
Assets 1,146.50
Liabilities 363.30
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 753.20
Operating Income -144.60
Net Income -263.30
Earnings Per Share Diluted n/a
Earnings Per Share Increase Decrease Reduction Performance Obligation n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -110.90
Cash from Investing 31.90
Cash from Financing 152.90

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-18 13G Millennium Management Llc 4.70
02-14 13G/A Camber Capital Management LP
02-14 13G/A Glenview Capital Management, Llc 5.97 22.54
02-13 13G/A Vanguard Group Inc 11.12 6.90
02-08 13G/A Wellington Management Group Llp 8.07 6.37
01-24 13G/A State Street Corp 5.25 -6.37
01-23 13G/A Integrated Core Strategies (us) Llc 4.00 -16.42
01-22 13G/A BlackRock Inc. 16.60 2.11

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-24 74,331 360,262 20.63
2024-04-23 46,846 387,124 12.10
2024-04-22 52,724 271,345 19.43
2024-04-19 48,317 237,743 20.32

(click for more detail)

Similar Companies
MRSN – Mersana Therapeutics, Inc. MRVI – Maravai LifeSciences Holdings, Inc.
MTEX – Mannatech, Incorporated NBIX – Neurocrine Biosciences, Inc.
NEOG – Neogen Corporation


Financial data and stock pages provided by
Fintel.io